相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RHAMM expression tunes the response of breast cancer cell lines to hyaluronan
Ana M. Carvalho et al.
ACTA BIOMATERIALIA (2022)
Modification of BRCA1-associated breast cancer risk by HMMR overexpression
Francesca Mateo et al.
NATURE COMMUNICATIONS (2022)
The Pro-fibrotic Response of Mesenchymal Leader Cells to Lens Wounding Involves Hyaluronic Acid, Its Receptor RHAMM, and Vimentin
A. Sue Menko et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation
Ana M. Carvalho et al.
ACTA BIOMATERIALIA (2021)
Hyaluronan Functions in Wound Repair That Are Captured to Fuel Breast Cancer Progression
Cornelia Tolg et al.
BIOMOLECULES (2021)
Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer
Yan-ping Tang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1
Sandra Burren et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha J. Paston et al.
FRONTIERS IN IMMUNOLOGY (2021)
Inhibiting FAK-Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells
Antoine Mousson et al.
CANCERS (2021)
AR-mTOR-SRF Axis Regulates HMMR Expression in Human Prostate Cancer Cells
You Sun et al.
BIOMOLECULES & THERAPEUTICS (2021)
High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer
Anthony Lin et al.
CANCER LETTERS (2021)
Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods
Xia Li et al.
FRONTIERS IN ONCOLOGY (2021)
Peptidomimetics: A Synthetic Tool for Inhibiting Protein-Protein Interactions in Cancer
Lloyd Mabonga et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2020)
Tumor microenvironment components: Allies of cancer progression
Pablo Igor Ribeiro Franco et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
RHAMM inhibits cell migration via the AKT/GSK3β/Snail axis in luminal A subtype breast cancer
Juan Wang et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2020)
TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR)
Shuai Ye et al.
MOLECULAR CANCER RESEARCH (2020)
Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization
Cornelia Tolg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor
Zhengcheng He et al.
CELLS (2020)
Antiproliferative Effect of 4-Methylumbelliferone in Epithelial Ovarian Cancer Cells Is Mediated by Disruption of Intracellular Homeostasis and Regulation of PI3K/AKT and MAPK Signaling
Garam An et al.
PHARMACEUTICS (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Rapamycin inhibits AR signaling pathway in prostate cancer by interacting with the FK1 domain of FKBP51
Jing Zhang et al.
BIOCHEMISTRY AND BIOPHYSICS REPORTS (2020)
RHAMM regulates the growth and migration of lung adenocarcinoma A549 cell line by regulating Cdc2/CyclinB1 and MMP9 genes
Feng Chen et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2020)
The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury
Zheng Cui et al.
MATRIX BIOLOGY (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression
Soyoung Choi et al.
MOLECULAR CANCER (2019)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
S. -A. Im et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment
Muhan Liu et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer
Ru He et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting Hyaluronan Interactions for Glioblastoma Stem Cell Therapy
Joline S. Hartheimer et al.
CANCER MICROENVIRONMENT (2019)
Phosphorylation of importin-α1 by CDK1-cyclin B1 controls mitotic spindle assembly
Li Guo et al.
JOURNAL OF CELL SCIENCE (2019)
Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis
Zhenhua Li et al.
ONCOLOGY LETTERS (2019)
4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
Noor A. Lokman et al.
CANCERS (2019)
Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
Yejinpeng Wang et al.
FRONTIERS IN ONCOLOGY (2019)
Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer
Dong Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Identification of key differentially expressed genes associated with non-small cell lung cancer by bioinformatics analyses
Yubo Xiao et al.
MOLECULAR MEDICINE REPORTS (2018)
Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer
Weilin Li et al.
ONCOGENE (2018)
Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells
Yao-Tseng Chen et al.
Oncotarget (2018)
Extracellular Matrix-receptor Interaction Signaling Genes Associated with Inferior Breast Cancer Survival
Ming-Hsin Yeh et al.
ANTICANCER RESEARCH (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma
Ying-Jian Song et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Kurt Engeland
CELL DEATH AND DIFFERENTIATION (2018)
RB Loss Promotes Prostate Cancer Metastasis
Chellappagounder Thangavel et al.
CANCER RESEARCH (2017)
Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial
Michael Schmitt et al.
ONCOTARGET (2017)
ERK signalling as a regulator of cell motility
Susumu Tanimura et al.
JOURNAL OF BIOCHEMISTRY (2017)
The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer
Valentina Mele et al.
ONCOTARGET (2017)
BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells
Zhengcheng He et al.
ONCOTARGET (2017)
Spindle Misorientation of Cerebral and Cerebellar Progenitors Is a Mechanistic Cause of Megalencephaly
Huaibiao Li et al.
STEM CELL REPORTS (2017)
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
Daley S. Morera et al.
BRITISH JOURNAL OF CANCER (2017)
Extracellular Matrix Receptor Expression in Subtypes of Lung Adenocarcinoma Potentiates Outgrowth of Micrometastases
Laura E. Stevens et al.
CANCER RESEARCH (2017)
Evaluation of the use of therapeutic peptides for cancer treatment
Susan Marqus et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis
Katerina Kouvidi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Prognostic significance of CD168 overexpression in colorectal cancer
Ke Wang et al.
ONCOLOGY LETTERS (2016)
Effects of RHAMM/HMMR-Selective Peptides on Survival of Breast Cancer Cells
N. P. Akent'eva et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers
Viktor Hendrik Koelzer et al.
HUMAN PATHOLOGY (2015)
Signaling Networks that Regulate Cell Migration
Peter Devreotes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
Biljana Stangeland et al.
ONCOTARGET (2015)
Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma
Xiao-Bo Cheng et al.
JOURNAL OF CANCER (2015)
4-Methylumbe liferone treatment and hyaluronan innibition as a therapeutic strategy in nflammation, autoimmunity, and cancer
Nadine Nagy et al.
FRONTIERS IN IMMUNOLOGY (2015)
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
Ignacio Blanco et al.
PLOS ONE (2015)
Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue
Fernando Korkes et al.
BJU INTERNATIONAL (2014)
Evaluation of protein biomarkers of prostate cancer aggressiveness
Anthony E. Rizzardi et al.
BMC CANCER (2014)
Elevated Hyaluronan and Hyaluronan-Mediated Motility Receptor Are Associated With Biochemical Failure in Patients With Intermediate-Grade Prostate Tumors
Anthony E. Rizzardi et al.
CANCER (2014)
HMMR Maintains the Stemness and Tumorigenicity of Glioblastoma Stem-like Cells
Jessica Tilghman et al.
CANCER RESEARCH (2014)
Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2
Helen Chen et al.
CELL CYCLE (2014)
Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectin
Claudia Meier et al.
JOURNAL OF PATHOLOGY (2014)
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility
Zhongyuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells
Ying-Li Hu et al.
SCIENTIFIC REPORTS (2014)
The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder
Christian Niedworok et al.
PLOS ONE (2013)
Prognostic Value of Discs Large Homolog 7 Transcript Levels in Prostate Cancer
Christian R. Gomez et al.
PLOS ONE (2013)
Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition
Pooja Mohan et al.
ONCOTARGET (2013)
A RHAMM Mimetic Peptide Blocks Hyaluronan Signaling and Reduces Inflammation and Fibrogenesis in Excisional Skin Wounds
Cornelia Tolg et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Immune Responses to RHAMM in Patients with Acute Myeloid Leukemia after Chemotherapy and Allogeneic Stem Cell Transplantation
R. Casalegno-Garduno et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia
Sylvia Snauwaert et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ
Deokbum Park et al.
MOLECULES AND CELLS (2012)
Targeting Hyaluronidase for Cancer Therapy: Antitumor Activity of Sulfated Hyaluronic Acid in Prostate Cancer Cells
Anaid Benitez et al.
CANCER RESEARCH (2011)
Role of Receptor for Hyaluronic Acid-mediated Motility (RHAMM) in Low Molecular Weight Hyaluronan (LMWHA)-mediated Fibrosarcoma Cell Adhesion
Katerina Kouvidi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR
Hiroko Hatano et al.
LABORATORY INVESTIGATION (2011)
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
Christopher A. Maxwell et al.
PLOS BIOLOGY (2011)
Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified Xenopus RHAMM
Han Shuo Yang et al.
CANCER SCIENCE (2010)
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
Jochen Greiner et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity
Cornelia Tolg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mechanisms of Motility in Metastasizing Cells
Mahmut Yilmaz et al.
MOLECULAR CANCER RESEARCH (2010)
Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia
K. Giannopoulos et al.
LEUKEMIA (2010)
RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease
Kilian M. Gust et al.
NEOPLASIA (2009)
Androgen receptor regulates CD168 expression and signaling in prostate cancer
Shi-Lung Lin et al.
CARCINOGENESIS (2008)
RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
Sindy Sohr et al.
CELL CYCLE (2008)
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
I. Zlobec et al.
GUT (2008)
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
Christopher Alan Maxwell et al.
JOURNAL OF CELL SCIENCE (2008)
Aurora - A kinase regulates breast cancer-associated gene 1 inhibition of centrosome-dependent microtubule nucleation
Satish Sankaran et al.
CANCER RESEARCH (2007)
Network modeling links breast cancer susceptibility and centrosome dysfunction
Miguel Angel Pujana et al.
NATURE GENETICS (2007)
Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON
Dahis Manzanares et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells
Sara R. Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hyaluronan stimulates transformation of androgen-independent prostate cancer
Shi-Lung Lin et al.
CARCINOGENESIS (2007)
Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model
Takayuki Amano et al.
JOURNAL OF NEUROSURGERY (2007)
Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair
Cornelia Tolg et al.
JOURNAL OF CELL BIOLOGY (2006)
Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis
Mio Shinohara et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly
Vladimir Joukov et al.
CELL (2006)
Identification of G2/M targets for the MAP kinase pathway by functional proteomics
Elisabeth C. Roberts et al.
PROTEOMICS (2006)
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia
J Greiner et al.
BLOOD (2005)
Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an example
CW Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The MAP kinase pathway is required for entry into mitosis and cell survival
X Liu et al.
ONCOGENE (2004)
XRHAMM functions in Ran-dependent microtubule nucleation and pole formation during anastral spindle assembly
AC Groen et al.
CURRENT BIOLOGY (2004)
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive. bromatosis (desmoid tumor)
C Tolg et al.
ONCOGENE (2003)
Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia
J Greiner et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Delivering the message: epimorphin and mammary epithelial morphogenesis
DC Radisky et al.
TRENDS IN CELL BIOLOGY (2003)
RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability
CA Maxwell et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: expression of a tumor-specific variant and association with microtubules
RX Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells
V Assmann et al.
JOURNAL OF PATHOLOGY (2001)
分享论文
